​

West Pharmaceutical Services (WST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

WST Stock Forecast

West Pharmaceutical Services (WST) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $372.13, with a high of $447.00 and a low of $295.00. This represents a 12.34% increase from the last price of $331.25.

$250 $290 $330 $370 $410 $450 High: $447 Avg: $372.13 Low: $295 Last Closed Price: $331.25

WST Stock Rating

West Pharmaceutical Services stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (73.33%), 3 Hold (20.00%), 1 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 15 1 3 11 0 Strong Sell Sell Hold Buy Strong Buy

WST Price Target Upside V Benchmarks

TypeNameUpside
StockWest Pharmaceutical Services12.34%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks17.33%

Price Target Trends

1M3M12M
# Anlaysts5621
Avg Price Target$407.40$406.17$344.43
Last Closing Price$331.25$331.25$331.25
Upside/Downside22.99%22.62%3.98%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 262111-115
Jun, 262103--15
May, 262103--15
Apr, 262103--15
Mar, 262113--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 27, 2026Evercore ISI$425.00$333.1227.58%28.30%
Jul 13, 2026BNP Paribas$447.00$353.7126.37%34.94%
Jul 09, 2026Morgan Stanley$365.00$353.683.20%10.19%
Jul 06, 2026Daniel MarkowitzEvercore ISI$410.00$359.2714.12%23.77%
Jul 02, 2026KeyBanc$390.00$365.006.85%17.74%
Jun 09, 2026Luke SergottBarclays$400.00$319.7525.10%20.75%
Apr 27, 2026Morgan Stanley$315.00$306.392.81%-4.91%
Apr 27, 2026Barclays$310.00$306.161.25%-6.42%
Feb 13, 2026Dan LeonardUBS$340.00$246.6037.88%2.64%
Feb 13, 2026Deutsche Bank$315.00$247.4927.28%-4.91%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 27, 2026Evercore ISIOutperformOutperformhold
Jul 15, 2026Cowen & Co.BuyBuyhold
Jul 13, 2026Exane BNP ParibasOutperforminitialise
Jul 06, 2026Evercore ISIOutperformOutperformhold
Jul 02, 2026KeyBancOverweightOverweighthold
Jun 09, 2026BarclaysOverweightupgrade
Jun 01, 2026Wolfe ResearchOutperformupgrade
Apr 24, 2026CitigroupBuyBuyhold
Apr 24, 2026Evercore ISIOutperformOutperformhold
Feb 13, 2026UBSBuyBuyhold

Financial Forecast

EPS Forecast

$6 $7 $8 $9 $10 $11 $12 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.90$7.88$7.99$6.75$6.83---
Avg Forecast$8.49$8.17$8.01$6.63$7.45$8.77$9.98$11.10
High Forecast$8.62$8.27$8.10$6.67$7.67$9.11$10.17$11.31
Low Forecast$8.40$8.10$7.96$6.55$7.30$8.29$9.82$10.92
Surprise %4.83%-3.55%-0.25%1.81%-8.32%---

Revenue Forecast

$3B $3B $3B $3B $4B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.83B$2.89B$2.95B$2.89B$3.07B---
Avg Forecast$2.81B$2.84B$2.96B$2.88B$3.04B$3.31B$3.50B$3.71B
High Forecast$2.84B$2.86B$3.00B$2.89B$3.06B$3.31B$3.52B$3.77B
Low Forecast$2.79B$2.82B$2.92B$2.85B$3.03B$3.31B$3.48B$3.67B
Surprise %0.70%1.77%-0.22%0.27%1.14%---

Net Income Forecast

$400M $500M $600M $700M $800M $900M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$661.80M$585.90M$593.40M$492.70M$493.70M---
Avg Forecast$503.69M$609.47M$593.40M$499.60M$563.43M$637.89M$749.00M$835.83M
High Forecast$604.43M$731.37M$712.08M$502.29M$577.28M$685.83M$765.83M$851.78M
Low Forecast$402.95M$487.58M$474.72M$493.31M$549.58M$623.92M$739.61M$822.61M
Surprise %31.39%-3.87%--1.38%-12.38%---

WST Forecast FAQ

Is West Pharmaceutical Services stock a buy?

West Pharmaceutical Services stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that West Pharmaceutical Services is a favorable investment for most analysts.

What is West Pharmaceutical Services's price target?

West Pharmaceutical Services's price target, set by 15 Wall Street analysts, averages $372.13 over the next 12 months. The price target range spans from $295 at the low end to $447 at the high end, suggesting a potential 12.34% change from the previous closing price of $331.25.

How does West Pharmaceutical Services stock forecast compare to its benchmarks?

West Pharmaceutical Services's stock forecast shows a 12.34% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (17.33%).

What is the breakdown of analyst ratings for West Pharmaceutical Services over the past three months?

  • July 2026: 13.33% Strong Buy, 73.33% Buy, 6.67% Hold, 0% Sell, 6.67% Strong Sell.
  • June 2026: 13.33% Strong Buy, 66.67% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 13.33% Strong Buy, 66.67% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is West Pharmaceutical Services’s EPS forecast?

West Pharmaceutical Services's average annual EPS forecast for its fiscal year ending in December 2026 is $8.77, marking a 28.40% increase from the reported $6.83 in 2025. Estimates for the following years are $9.98 in 2027, and $11.1 in 2028.

What is West Pharmaceutical Services’s revenue forecast?

West Pharmaceutical Services's average annual revenue forecast for its fiscal year ending in December 2026 is $3.31B, reflecting a 7.67% increase from the reported $3.07B in 2025. The forecast for 2027 is $3.5B, and $3.71B for 2028.

What is West Pharmaceutical Services’s net income forecast?

West Pharmaceutical Services's net income forecast for the fiscal year ending in December 2026 stands at $637.89M, representing an 29.21% increase from the reported $493.7M in 2025. Projections indicate $749M in 2027, and $835.83M in 2028.